Cerebral hemodynamics in patients with multiple sclerosis

Simona Lattanzi1, Maria Cristina Acciarri1, Maura Danni1

  • 1Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy.

Abstract

Insights

Multiple sclerosis patients exhibit impaired cerebral hemodynamics, with significantly reduced cerebrovascular reactivity observed in secondary progressive MS compared to relapsing-remitting MS. This suggests vascular dysfunction may contribute to MS pathophysiology.

Area of Science:

  • Neurology
  • Neuroscience
  • Vascular Biology

Background:

  • Multiple sclerosis (MS) is primarily viewed as an autoimmune inflammatory disease affecting the central nervous system.
  • Emerging evidence suggests that alterations in brain vasculature may also play a role in MS pathophysiology.
  • Understanding cerebral hemodynamics in MS is crucial for a comprehensive view of the disease.

Purpose of the Study:

  • To evaluate cerebral hemodynamics in patients diagnosed with multiple sclerosis.
  • To investigate the relationship between cerebral hemodynamic status and disease characteristics in MS.
  • To compare cerebrovascular reactivity between different MS phenotypes and healthy controls.

Main Methods:

  • Recruited 80 patients with MS and 80 age- and sex-matched healthy controls.
  • Assessed cerebral hemodynamics using transcranial Doppler ultrasonography.
  • Measured cerebral vasomotor reactivity (CVR) to hypercapnia via the breath-holding index (BHI).

Main Results:

  • Patients with MS demonstrated significantly reduced CVR compared to healthy controls.
  • Breath-holding index (BHI) values were significantly lower in secondary progressive (SP)-MS (0.51±0.20) than in relapsing-remitting (RR)-MS (0.87±0.18) patients.
  • The SP MS phenotype was identified as an independent predictor of lower BHI values, indicating impaired cerebral hemodynamics.

Conclusions:

  • Cerebrovascular hemodynamic insufficiency is evident in multiple sclerosis patients.
  • This vascular dysfunction may be a consequence of the downstream effects of neuro-inflammatory processes in MS.
  • Findings highlight the potential contribution of vascular factors to MS progression.

Related Concept Videos